Search For "biosimilars"
SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expan
Updated : 2 weeks, 3 days ago IST
San Jose [Costa Rica]/ Raichur (Karnataka) [India], February 25: SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd. (SBPL), a fully integrated biopharmaceutical subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), announce a
Read More
India, EU can be supplier of affordable medicines worldwide as India-EU FT
Updated : 1 month, 2 weeks ago IST
The conclusion of the India-European Union Free Trade Agreement (India-EU FTA) has opened major opportunities for the two regions to emerge as a global supplier of affordable and quality medicines, according to the Indian Pharmaceutical Alliance (IPA).
Read More
USFDA moves to accelerate biosimilar development and lower drug costs
Updated : 4 months, 2 weeks ago IST
The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to treat serious and chronic diseases.
Read More
India's pharma sector registers strong Q2 FY25 growth, driven by N America
Updated : 1 year, 3 months ago IST
The major pharmaceutical companies of the country reported a 10 per cent year-on-year (YoY) growth in the second quarter of FY25, largely driven by strong performance in North America and the domestic market, according to a report by Axis Securities.
Read More
Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Science
Updated : 1 year, 4 months ago IST
Gurgaon (Haryana) [India], November 6: Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise today announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosm
Read More
Indian pharmaceutical industry moving ahead from generics to biosimilars a
Updated : 1 year, 8 months ago IST
"From generics, we are now moving very fast into biosimilars. We are moving equally fast in MedTech. And you will see that in the years to come, this industry will grow rapidly further, and most independent market-based research firms project the Indian pharma and MedTech industry as the ind
Read More
Flawless Pharma Pvt Ltd to invest USD 100 Million in buyout of Assets &
Updated : 2 years, 7 months ago IST
New Delhi [India], August 2: Flawless Pharma Private Limited a research-based integrated pharmaceutical company involved in niche API manufacturing & marketing of pharmaceutical ingredient supplier for foremost formulators with services, including APIs, custom pharmaceutical services, ge
Read More
Aaquaries Global Industries Limited mulls investment of USD 200 million in
Updated : 3 years ago IST
New Delhi [India], March 6 (ANI/SRV): Aaquaries Global Industries Limited, a research-based integrated pharmaceutical company involved in niche API manufacturing & marketing of pharmaceutical ingredient supplier for foremost formulators with services, including APIs, custom pharmaceutica
Read More
Biocon Biologics completes acquisition of Viatris' Global Biosimilars Busi
Updated : 3 years, 3 months ago IST
Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Vi
Read More
Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.33
Updated : 4 years ago IST
Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ: VTRS). Accordingly, Biocon Biologics Ltd (BBL) will acquire Viatris'
Read More
India tops the chart for approved biosimilars and clinical trials surpassi
Updated : 4 years, 5 months ago IST
Bengaluru (Karnataka) [India], September 24 (ANI/PRNewswire): With an overarching theme of 'Ideate and Innovate' and new prospects of Intellectual Property (IP) in the Indian pharmaceutical industry, Informa Pharma Intelligence, the Knowledge Partner of Pharma IPR 2021, has today concluded t
Read More
Biocon posts Rs 257 crore profit for Q4 on strong biosimilar business
Updated : 4 years, 10 months ago IST
Bengaluru (Karnataka) [India], April 29 (ANI): Biopharmaceuticals major Biocon Ltd on Thursday reported net profit of Rs 257 crore in the fourth quarter of FY21, up 95 per cent from Rs 132 crore in Q4 FY20.
Read More